nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—type 2 diabetes mellitus—type 1 diabetes mellitus	0.855	1	CtDrD
Irbesartan—JUN—peripheral nervous system—type 1 diabetes mellitus	0.00275	0.194	CbGeAlD
Irbesartan—JUN—nerve—type 1 diabetes mellitus	0.00215	0.151	CbGeAlD
Irbesartan—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.00174	0.036	CcSEcCtD
Irbesartan—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.00156	0.0324	CcSEcCtD
Irbesartan—JUN—islet of Langerhans—type 1 diabetes mellitus	0.00104	0.0732	CbGeAlD
Irbesartan—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.000997	0.0207	CcSEcCtD
Irbesartan—Proteinuria—Ramipril—type 1 diabetes mellitus	0.000997	0.0207	CcSEcCtD
Irbesartan—Protein urine present—Ramipril—type 1 diabetes mellitus	0.000984	0.0204	CcSEcCtD
Irbesartan—Drug interaction—Ramipril—type 1 diabetes mellitus	0.000945	0.0196	CcSEcCtD
Irbesartan—Vasculitis—Ramipril—type 1 diabetes mellitus	0.000898	0.0186	CcSEcCtD
Irbesartan—JUN—retina—type 1 diabetes mellitus	0.000888	0.0625	CbGeAlD
Irbesartan—JUN—nephron tubule—type 1 diabetes mellitus	0.000837	0.0589	CbGeAlD
Irbesartan—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.000827	0.0171	CcSEcCtD
Irbesartan—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.000784	0.0162	CcSEcCtD
Irbesartan—JUN—cardiovascular system—type 1 diabetes mellitus	0.000751	0.0529	CbGeAlD
Irbesartan—JUN—kidney—type 1 diabetes mellitus	0.000735	0.0518	CbGeAlD
Irbesartan—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.000735	0.0152	CcSEcCtD
Irbesartan—JUN—pancreas—type 1 diabetes mellitus	0.00073	0.0514	CbGeAlD
Irbesartan—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.000724	0.015	CcSEcCtD
Irbesartan—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.000718	0.0149	CcSEcCtD
Irbesartan—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.000705	0.0146	CcSEcCtD
Irbesartan—Renal impairment—Ramipril—type 1 diabetes mellitus	0.000668	0.0138	CcSEcCtD
Irbesartan—Arthritis—Ramipril—type 1 diabetes mellitus	0.000655	0.0136	CcSEcCtD
Irbesartan—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.000649	0.0134	CcSEcCtD
Irbesartan—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.000639	0.0132	CcSEcCtD
Irbesartan—JUN—lymphoid tissue—type 1 diabetes mellitus	0.000632	0.0445	CbGeAlD
Irbesartan—AGTR1—nephron tubule—type 1 diabetes mellitus	0.00063	0.0444	CbGeAlD
Irbesartan—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.000587	0.0122	CcSEcCtD
Irbesartan—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.000581	0.012	CcSEcCtD
Irbesartan—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000581	0.012	CcSEcCtD
Irbesartan—Breast disorder—Ramipril—type 1 diabetes mellitus	0.000575	0.0119	CcSEcCtD
Irbesartan—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.000573	0.0119	CcSEcCtD
Irbesartan—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.000573	0.0119	CcSEcCtD
Irbesartan—AGTR1—cardiovascular system—type 1 diabetes mellitus	0.000566	0.0398	CbGeAlD
Irbesartan—AGTR1—kidney—type 1 diabetes mellitus	0.000554	0.039	CbGeAlD
Irbesartan—Asthma—Ramipril—type 1 diabetes mellitus	0.00055	0.0114	CcSEcCtD
Irbesartan—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00055	0.0114	CcSEcCtD
Irbesartan—Influenza—Ramipril—type 1 diabetes mellitus	0.00055	0.0114	CcSEcCtD
Irbesartan—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.000539	0.0112	CcSEcCtD
Irbesartan—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.000536	0.0111	CcSEcCtD
Irbesartan—Neutropenia—Ramipril—type 1 diabetes mellitus	0.000514	0.0106	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.000511	0.0106	CcSEcCtD
Irbesartan—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000502	0.0104	CcSEcCtD
Irbesartan—Weight increased—Ramipril—type 1 diabetes mellitus	0.0005	0.0104	CcSEcCtD
Irbesartan—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.000483	0.01	CcSEcCtD
Irbesartan—Renal failure—Ramipril—type 1 diabetes mellitus	0.000482	0.00998	CcSEcCtD
Irbesartan—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.000481	0.00995	CcSEcCtD
Irbesartan—Jaundice—Ramipril—type 1 diabetes mellitus	0.000478	0.0099	CcSEcCtD
Irbesartan—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.000477	0.00987	CcSEcCtD
Irbesartan—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.000477	0.00987	CcSEcCtD
Irbesartan—AGTR1—lymphoid tissue—type 1 diabetes mellitus	0.000476	0.0335	CbGeAlD
Irbesartan—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000464	0.0096	CcSEcCtD
Irbesartan—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000462	0.00958	CcSEcCtD
Irbesartan—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000457	0.00948	CcSEcCtD
Irbesartan—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00044	0.00911	CcSEcCtD
Irbesartan—Losartan—ACE—type 1 diabetes mellitus	0.000435	0.445	CrCbGaD
Irbesartan—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000434	0.00898	CcSEcCtD
Irbesartan—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000432	0.00896	CcSEcCtD
Irbesartan—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000424	0.00878	CcSEcCtD
Irbesartan—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00041	0.0085	CcSEcCtD
Irbesartan—Flushing—Ramipril—type 1 diabetes mellitus	0.000408	0.00846	CcSEcCtD
Irbesartan—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000398	0.00823	CcSEcCtD
Irbesartan—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000397	0.00821	CcSEcCtD
Irbesartan—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000393	0.00814	CcSEcCtD
Irbesartan—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000383	0.00793	CcSEcCtD
Irbesartan—Erythema—Ramipril—type 1 diabetes mellitus	0.000383	0.00793	CcSEcCtD
Irbesartan—Tension—Ramipril—type 1 diabetes mellitus	0.000376	0.00779	CcSEcCtD
Irbesartan—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000375	0.00777	CcSEcCtD
Irbesartan—Nervousness—Ramipril—type 1 diabetes mellitus	0.000372	0.00771	CcSEcCtD
Irbesartan—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000368	0.00763	CcSEcCtD
Irbesartan—Valsartan—ALB—type 1 diabetes mellitus	0.000365	0.373	CrCbGaD
Irbesartan—Tremor—Ramipril—type 1 diabetes mellitus	0.000359	0.00743	CcSEcCtD
Irbesartan—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000355	0.00736	CcSEcCtD
Irbesartan—Agitation—Ramipril—type 1 diabetes mellitus	0.000352	0.00729	CcSEcCtD
Irbesartan—Angioedema—Ramipril—type 1 diabetes mellitus	0.00035	0.00725	CcSEcCtD
Irbesartan—Malaise—Ramipril—type 1 diabetes mellitus	0.000345	0.00716	CcSEcCtD
Irbesartan—Vertigo—Ramipril—type 1 diabetes mellitus	0.000344	0.00713	CcSEcCtD
Irbesartan—Syncope—Ramipril—type 1 diabetes mellitus	0.000344	0.00712	CcSEcCtD
Irbesartan—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000343	0.0071	CcSEcCtD
Irbesartan—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000337	0.00697	CcSEcCtD
Irbesartan—Cough—Ramipril—type 1 diabetes mellitus	0.000334	0.00692	CcSEcCtD
Irbesartan—Chest pain—Ramipril—type 1 diabetes mellitus	0.000326	0.00676	CcSEcCtD
Irbesartan—Myalgia—Ramipril—type 1 diabetes mellitus	0.000326	0.00676	CcSEcCtD
Irbesartan—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000326	0.00676	CcSEcCtD
Irbesartan—Anxiety—Ramipril—type 1 diabetes mellitus	0.000325	0.00673	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000324	0.00671	CcSEcCtD
Irbesartan—Discomfort—Ramipril—type 1 diabetes mellitus	0.000322	0.00667	CcSEcCtD
Irbesartan—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000319	0.00661	CcSEcCtD
Irbesartan—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000313	0.00648	CcSEcCtD
Irbesartan—Oedema—Ramipril—type 1 diabetes mellitus	0.000313	0.00648	CcSEcCtD
Irbesartan—Shock—Ramipril—type 1 diabetes mellitus	0.000308	0.00637	CcSEcCtD
Irbesartan—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000307	0.00635	CcSEcCtD
Irbesartan—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000306	0.00634	CcSEcCtD
Irbesartan—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000305	0.00632	CcSEcCtD
Irbesartan—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000304	0.00629	CcSEcCtD
Irbesartan—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000302	0.00626	CcSEcCtD
Irbesartan—CYP2C8—kidney—type 1 diabetes mellitus	0.0003	0.0211	CbGeAlD
Irbesartan—Anorexia—Ramipril—type 1 diabetes mellitus	0.000298	0.00617	CcSEcCtD
Irbesartan—Hypotension—Ramipril—type 1 diabetes mellitus	0.000292	0.00605	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000285	0.0059	CcSEcCtD
Irbesartan—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000281	0.00581	CcSEcCtD
Irbesartan—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000279	0.00577	CcSEcCtD
Irbesartan—Somnolence—Ramipril—type 1 diabetes mellitus	0.000278	0.00576	CcSEcCtD
Irbesartan—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000275	0.0057	CcSEcCtD
Irbesartan—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000273	0.0192	CbGeAlD
Irbesartan—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000272	0.00563	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00027	0.00559	CcSEcCtD
Irbesartan—Fatigue—Ramipril—type 1 diabetes mellitus	0.00027	0.00558	CcSEcCtD
Irbesartan—Constipation—Ramipril—type 1 diabetes mellitus	0.000267	0.00554	CcSEcCtD
Irbesartan—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000258	0.00534	CcSEcCtD
Irbesartan—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000256	0.0053	CcSEcCtD
Irbesartan—PTGS1—cardiovascular system—type 1 diabetes mellitus	0.000249	0.0175	CbGeAlD
Irbesartan—Urticaria—Ramipril—type 1 diabetes mellitus	0.000248	0.00514	CcSEcCtD
Irbesartan—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000247	0.00512	CcSEcCtD
Irbesartan—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000247	0.00512	CcSEcCtD
Irbesartan—PTGS1—kidney—type 1 diabetes mellitus	0.000243	0.0171	CbGeAlD
Irbesartan—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00023	0.00477	CcSEcCtD
Irbesartan—Asthenia—Ramipril—type 1 diabetes mellitus	0.000224	0.00465	CcSEcCtD
Irbesartan—Pruritus—Ramipril—type 1 diabetes mellitus	0.000221	0.00458	CcSEcCtD
Irbesartan—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000214	0.00443	CcSEcCtD
Irbesartan—Dizziness—Ramipril—type 1 diabetes mellitus	0.000207	0.00428	CcSEcCtD
Irbesartan—CYP3A4—kidney—type 1 diabetes mellitus	0.000203	0.0143	CbGeAlD
Irbesartan—CYP2D6—kidney—type 1 diabetes mellitus	0.0002	0.0141	CbGeAlD
Irbesartan—Vomiting—Ramipril—type 1 diabetes mellitus	0.000199	0.00412	CcSEcCtD
Irbesartan—Rash—Ramipril—type 1 diabetes mellitus	0.000197	0.00408	CcSEcCtD
Irbesartan—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000197	0.00408	CcSEcCtD
Irbesartan—Headache—Ramipril—type 1 diabetes mellitus	0.000196	0.00406	CcSEcCtD
Irbesartan—Nausea—Ramipril—type 1 diabetes mellitus	0.000186	0.00385	CcSEcCtD
Irbesartan—Losartan—ALB—type 1 diabetes mellitus	0.000178	0.182	CrCbGaD
Irbesartan—AGTR1—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.07e-05	0.000376	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD86—type 1 diabetes mellitus	3.07e-05	0.000376	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	3.01e-05	0.000369	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3e-05	0.000368	CbGpPWpGaD
Irbesartan—JUN—Immune System—ITPR3—type 1 diabetes mellitus	2.99e-05	0.000367	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	2.99e-05	0.000366	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFIH1—type 1 diabetes mellitus	2.97e-05	0.000364	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—HBA2—type 1 diabetes mellitus	2.97e-05	0.000364	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.96e-05	0.000362	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—EGFR—type 1 diabetes mellitus	2.92e-05	0.000358	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.91e-05	0.000357	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	2.91e-05	0.000356	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	2.9e-05	0.000355	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.88e-05	0.000353	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL6—type 1 diabetes mellitus	2.88e-05	0.000353	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ITPR3—type 1 diabetes mellitus	2.87e-05	0.000351	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—HLA-B—type 1 diabetes mellitus	2.86e-05	0.00035	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—IL6—type 1 diabetes mellitus	2.85e-05	0.000349	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	2.85e-05	0.000349	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	2.85e-05	0.000349	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—G6PC2—type 1 diabetes mellitus	2.79e-05	0.000342	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.77e-05	0.000339	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—ERBB3—type 1 diabetes mellitus	2.76e-05	0.000339	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	2.72e-05	0.000334	CbGpPWpGaD
Irbesartan—JUN—Immune System—PTPN2—type 1 diabetes mellitus	2.72e-05	0.000333	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	2.71e-05	0.000333	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	2.71e-05	0.000333	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SST—type 1 diabetes mellitus	2.71e-05	0.000332	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—HBA1—type 1 diabetes mellitus	2.7e-05	0.000331	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.7e-05	0.000331	CbGpPWpGaD
Irbesartan—JUN—Immune System—B2M—type 1 diabetes mellitus	2.69e-05	0.000329	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOC3—type 1 diabetes mellitus	2.68e-05	0.000329	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL6—type 1 diabetes mellitus	2.64e-05	0.000324	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GSTT1—type 1 diabetes mellitus	2.63e-05	0.000323	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	2.63e-05	0.000322	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.59e-05	0.000317	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.55e-05	0.000313	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CRP—type 1 diabetes mellitus	2.53e-05	0.00031	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.52e-05	0.000308	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—STAT3—type 1 diabetes mellitus	2.47e-05	0.000303	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.44e-05	0.000299	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.42e-05	0.000297	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.42e-05	0.000297	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ABCC8—type 1 diabetes mellitus	2.42e-05	0.000297	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—GCG—type 1 diabetes mellitus	2.42e-05	0.000296	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	2.38e-05	0.000291	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DPB1—type 1 diabetes mellitus	2.38e-05	0.000291	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-E—type 1 diabetes mellitus	2.34e-05	0.000286	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.33e-05	0.000285	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.32e-05	0.000284	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GAL—type 1 diabetes mellitus	2.32e-05	0.000284	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL11—type 1 diabetes mellitus	2.29e-05	0.000281	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL20—type 1 diabetes mellitus	2.29e-05	0.000281	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.29e-05	0.00028	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL6—type 1 diabetes mellitus	2.28e-05	0.00028	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.26e-05	0.000277	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.25e-05	0.000276	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTLA4—type 1 diabetes mellitus	2.25e-05	0.000276	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD80—type 1 diabetes mellitus	2.24e-05	0.000274	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	2.19e-05	0.000268	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.16e-05	0.000264	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD79A—type 1 diabetes mellitus	2.15e-05	0.000263	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—type 1 diabetes mellitus	2.15e-05	0.000263	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SST—type 1 diabetes mellitus	2.13e-05	0.000261	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.12e-05	0.000259	CbGpPWpGaD
Irbesartan—JUN—Immune System—PRKCQ—type 1 diabetes mellitus	2.11e-05	0.000258	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GCG—type 1 diabetes mellitus	2.1e-05	0.000257	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.05e-05	0.000251	CbGpPWpGaD
Irbesartan—JUN—Immune System—VAV1—type 1 diabetes mellitus	2.05e-05	0.000251	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.05e-05	0.000251	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DQA1—type 1 diabetes mellitus	1.98e-05	0.000243	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CD86—type 1 diabetes mellitus	1.97e-05	0.000241	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.93e-05	0.000237	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HBA2—type 1 diabetes mellitus	1.92e-05	0.000235	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—KCNJ11—type 1 diabetes mellitus	1.91e-05	0.000234	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.9e-05	0.000232	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TYK2—type 1 diabetes mellitus	1.89e-05	0.000231	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.88e-05	0.00023	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.87e-05	0.000229	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DQB1—type 1 diabetes mellitus	1.85e-05	0.000227	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.82e-05	0.000224	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.82e-05	0.000223	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.81e-05	0.000222	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.81e-05	0.000222	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—G6PC2—type 1 diabetes mellitus	1.8e-05	0.000221	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD86—type 1 diabetes mellitus	1.79e-05	0.000219	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	1.78e-05	0.000218	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CAT—type 1 diabetes mellitus	1.78e-05	0.000218	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.78e-05	0.000218	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.77e-05	0.000217	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.77e-05	0.000216	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40LG—type 1 diabetes mellitus	1.75e-05	0.000215	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.75e-05	0.000214	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD8A—type 1 diabetes mellitus	1.73e-05	0.000212	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—type 1 diabetes mellitus	1.73e-05	0.000211	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.72e-05	0.000211	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.71e-05	0.000209	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD4—type 1 diabetes mellitus	1.71e-05	0.000209	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-B—type 1 diabetes mellitus	1.67e-05	0.000204	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	1.62e-05	0.000198	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.61e-05	0.000197	CbGpPWpGaD
Irbesartan—JUN—Immune System—ERBB3—type 1 diabetes mellitus	1.61e-05	0.000197	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.6e-05	0.000197	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SST—type 1 diabetes mellitus	1.59e-05	0.000195	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.58e-05	0.000194	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	1.57e-05	0.000193	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	1.56e-05	0.000192	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	1.56e-05	0.000191	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2RA—type 1 diabetes mellitus	1.56e-05	0.000191	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.55e-05	0.000189	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-A—type 1 diabetes mellitus	1.54e-05	0.000189	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	1.52e-05	0.000187	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	1.52e-05	0.000186	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	1.51e-05	0.000185	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	1.48e-05	0.000182	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	1.48e-05	0.000181	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.48e-05	0.000181	CbGpPWpGaD
Irbesartan—JUN—Immune System—CRP—type 1 diabetes mellitus	1.47e-05	0.00018	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	1.47e-05	0.00018	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.47e-05	0.00018	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CD80—type 1 diabetes mellitus	1.44e-05	0.000176	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GCG—type 1 diabetes mellitus	1.42e-05	0.000173	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DRB1—type 1 diabetes mellitus	1.41e-05	0.000173	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.39e-05	0.000171	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.37e-05	0.000168	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.37e-05	0.000168	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.36e-05	0.000167	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—INS—type 1 diabetes mellitus	1.36e-05	0.000166	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.35e-05	0.000165	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.34e-05	0.000164	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	1.33e-05	0.000163	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.32e-05	0.000162	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.32e-05	0.000162	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.31e-05	0.000161	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.31e-05	0.00016	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD80—type 1 diabetes mellitus	1.3e-05	0.00016	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	1.28e-05	0.000157	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	1.27e-05	0.000156	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	1.25e-05	0.000154	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	1.24e-05	0.000151	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.21e-05	0.000149	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—EGFR—type 1 diabetes mellitus	1.2e-05	0.000147	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.2e-05	0.000147	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.19e-05	0.000146	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	1.18e-05	0.000145	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—INS—type 1 diabetes mellitus	1.18e-05	0.000144	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD86—type 1 diabetes mellitus	1.15e-05	0.000141	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.13e-05	0.000138	CbGpPWpGaD
Irbesartan—JUN—Immune System—TYK2—type 1 diabetes mellitus	1.1e-05	0.000135	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.1e-05	0.000134	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	1.09e-05	0.000133	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—type 1 diabetes mellitus	1.08e-05	0.000132	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—INS—type 1 diabetes mellitus	1.07e-05	0.00013	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	1.04e-05	0.000128	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.04e-05	0.000128	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NOS3—type 1 diabetes mellitus	1.03e-05	0.000127	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.03e-05	0.000126	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—type 1 diabetes mellitus	1.03e-05	0.000126	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	1.03e-05	0.000126	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.03e-05	0.000126	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.02e-05	0.000125	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	1.01e-05	0.000124	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.01e-05	0.000124	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—type 1 diabetes mellitus	1.01e-05	0.000124	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.01e-05	0.000124	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	1.01e-05	0.000123	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—type 1 diabetes mellitus	1e-05	0.000123	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	1e-05	0.000123	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—type 1 diabetes mellitus	9.95e-06	0.000122	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	9.82e-06	0.00012	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	9.76e-06	0.00012	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	9.68e-06	0.000119	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	9.59e-06	0.000117	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.52e-06	0.000117	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.34e-06	0.000114	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—type 1 diabetes mellitus	9.23e-06	0.000113	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—type 1 diabetes mellitus	9.18e-06	0.000113	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—type 1 diabetes mellitus	9.15e-06	0.000112	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	8.83e-06	0.000108	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	8.6e-06	0.000105	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	8.57e-06	0.000105	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	8.49e-06	0.000104	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.49e-06	0.000104	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD80—type 1 diabetes mellitus	8.42e-06	0.000103	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	8.39e-06	0.000103	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	8.06e-06	9.88e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	8.01e-06	9.82e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	7.99e-06	9.79e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—INS—type 1 diabetes mellitus	7.96e-06	9.75e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	7.94e-06	9.73e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.93e-06	9.72e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—type 1 diabetes mellitus	7.92e-06	9.7e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.88e-06	9.65e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	7.87e-06	9.64e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	7.8e-06	9.56e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.72e-06	9.45e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—STAT3—type 1 diabetes mellitus	7.7e-06	9.43e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.7e-06	9.43e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	7.64e-06	9.36e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	7.26e-06	8.89e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.19e-06	8.81e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.11e-06	8.71e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—EGFR—type 1 diabetes mellitus	7e-06	8.57e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.98e-06	8.55e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	6.83e-06	8.37e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	6.79e-06	8.32e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	6.67e-06	8.17e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.66e-06	8.16e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—INS—type 1 diabetes mellitus	6.64e-06	8.14e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	6.64e-06	8.13e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	6.47e-06	7.92e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	6.27e-06	7.68e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	6.22e-06	7.61e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.14e-06	7.53e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	6.09e-06	7.46e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.06e-06	7.42e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—type 1 diabetes mellitus	5.93e-06	7.27e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.92e-06	7.26e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—type 1 diabetes mellitus	5.92e-06	7.25e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	5.83e-06	7.14e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	5.6e-06	6.86e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—type 1 diabetes mellitus	5.38e-06	6.59e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	5.31e-06	6.51e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	5.31e-06	6.5e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	5.27e-06	6.46e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	5.26e-06	6.45e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	5.24e-06	6.42e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	5.14e-06	6.3e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.98e-06	6.1e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.65e-06	5.7e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.52e-06	5.54e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	4.5e-06	5.51e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	4.29e-06	5.26e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	4.1e-06	5.02e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	3.93e-06	4.82e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	3.76e-06	4.61e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.52e-06	4.32e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	3.49e-06	4.28e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—type 1 diabetes mellitus	3.48e-06	4.26e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.47e-06	4.25e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.23e-06	3.96e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	3.2e-06	3.92e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	3.09e-06	3.78e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	3.06e-06	3.75e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	2.98e-06	3.66e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.74e-06	3.35e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.62e-06	3.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.3e-06	2.82e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.11e-06	2.59e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.02e-06	2.47e-05	CbGpPWpGaD
